The Effects of Tuberculosis Treatment on Quality of Life, Anxiety and Depression

Özet

Objectives: This study aims to observe the health-related quality of life and depression and anxiety symptomsof newly diagnosed patients who were taking four-drug anti-tuberculosis (anti-TB) therapy during the treatment period.Methods: The TB-diagnosed patients who were taking four-drug TB therapy and suitable for this study werefollowed up during the treatment period in the providence of Eskişehir. The patients were assessed accordingto the Short From-36 (SF-36) health quality, Beck depression, and Beck anxiety scales at three months and atthe end of this study (six months).Results: Significant improvements were observed in all SF-36 components at the end of this study (p< 0.001).When compared with the beginning and the end of the treatment, there was a statistically significant decreasein Beck depression and anxiety scores (p<0.001).Conclusion: Improvement in the patients’ Beck depression–anxiety and life quality scores without additionalpsychiatric treatment is an important finding. These scientific outcomes show that, like other chronic diseases,TB may cause psychiatric problems.